Stem cells in heart failure some considerations
Article Sidebar
Main Article Content
Article Details
Copyright (c) 2018 Benetti F, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Stem Cell Therapy and Transplantation is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.
License: Copyright © 2017 - 2025 | 
Open Access by Journal of Stem Cell Therapy and Transplantation is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.
With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.
Compliance 'CC BY' license helps in:
| Permission to read and download | ✓ |
| Permission to display in a repository | ✓ |
| Permission to translate | ✓ |
| Commercial uses of manuscript | ✓ |
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
Meerson FZ. The myocardium in hiperfunction, hipertrophy and heart failure. Circ Reserch. 1969; 25: 1-163. Ref.: https://goo.gl/ZWF8iV
Zak R. Cardiac hipertrophy: biochemical and cellular relationships. Hosp Pract (Off Ed). 1983; 18: 85-97. Ref.: https://goo.gl/AVUL1h
Prosper F, Pérez A, Merino J, Gregorio R, Chachques JC, et al. Adult stem cells for myocardial repair. Basic Appl Myol. 2003; 13: 15-22. Ref.: https://goo.gl/yJtHWQ
Colucci WS, Braunwald E. Patophisiology of heart failure in Braunwald¨s Heart Disease 5th edition Saunders company 1997.
Prokop D. Marrow Stromal cells as Stem Cells for nonhematopoietic tissues. Science. 1997; 276: 71-76. Ref.: https://goo.gl/JfAJZv
Pittenger MF, Makay A, Beck SC, Jaiswal RK, Douglas R, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-147. Ref.: https://goo.gl/mzszL2
Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, et al. Cardiomyocites can be generated from marrow stromal cells in vitro. J Clin Invest. 1999; 105: 697-705. Ref.: https://goo.gl/8F6TX2
Xu M, Wani M, Dai YS, Wang J, Yan M, et al. Differentiation of bone marrow stromal cells into cardiac phenotype requires intracellular communication with myocites. Circulation. 2004; 110: 2658-2665. Ref.: https://goo.gl/iiSDqg
Chedrawy EG, Wang JS, Nguyen DM, Shum-Tim D, Chiu RCJ. Incorporation and integration of implanted myogenic and stem cells into native myocardial fibres: anatomic basis for functional improvements. J of Thoracic and Cardiovascular Surgery. 2002; 124: 584-590. Ref.: https://goo.gl/nyJhHB
Pittenger MF, Bradley JM. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res. 2004; 95: 9-20. Ref.: https://goo.gl/Hcthfk
Vilas-Boas F, Feitosa GS, Soares MB, Pinho-Filho JA, Mota A. Bone marrow cell transplantation to the myocardium of a patient with heart failure due to Chagas disease. Arq Bras Cardiol. 2004; 82: 185-187. Ref.: https://goo.gl/XoWhvY
Benetti F, Viña RF, Patel AN. OPCABG plus simultaneous autologus stem cells implants TCTMD.com. 2003.
Patel AN, Geffner L, Vina RF, Saslavsky J, Urschel HV, Jr. Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: A prospective randomized study. J Thoracic and Cardiovascular Surgery. 2005; 130: 1631-1638. Ref.: https://goo.gl/UayHSM
Comella K, Parcero J, Bansal H, Perez J, Lopez J, et al. Effects of the intramyocardial implantation of stromal vascular fraction in patients with chronic ischemic cardiomyopathy. J Transl Med. 2016; 14: 158. Ref.: https://goo.gl/Nvzyk1
Anastasiadis K, Antonitsis P, Westaby S, Reginald A, Sultan S, et al. Implantation of a Novel Allogeneic Mesenchymal Precursor Cell Type in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting: an Open Label Phase IIa Trial. Journal of Cardiovascular Translational Research. 2016; 9: 202-213. Ref.: https://goo.gl/TCPQTo
Poulin MF, Deka A, Mohamedali B, Schaer GL. Clinical Benefits of Stem Cells for A Systematic Review of the Existing Data and Ongoing Trials. Cell Transplant. 2016; 25: 1911-1923. Ref.: https://goo.gl/HJs294
Traverse JH, Henry TD, Pepine CJ, Willerson JT, Chugh AR, et al. The TIME Trial-Effect of Timing of Stem Cell Delivery Following ST-Elevation Myocardial Infarction on the Recovery of Global and Regional Left Ventricular Function: Final 2-Year Analysis. Circulation Research. 2017. Ref.: https://goo.gl/pSRHsb
Benetti F, Peñherrera E, Maldonado T, Vera YD, Subramanian V, et al. Direct Myocardial Implantation of Human Fetal Stem Cells in Heart Failure Patients: Long-term Results. The Heart Surgery Forum. 2010; 13: 31-35. Ref.: https://goo.gl/gsu9jR